• Project: Drug substance development for pain reduction

    The project aims to develop a new, more effective technology for synthesizing an active pharmaceutical ingredient (API) for a drug used primarily as a pain reliever for moderate to severe pain. The API is used in both human and veterinary pharmaceuticals. Its current uses include treatment for migraines, post-surgery pain relief, and chronic pain relief. The project budget is 249 208 EUR, of which 60% is co-financed by the Estonian Business and Innovation Agency. Project period: from January 1st to August 31th 2023.

    Read more
  • A Day of Discovery: BÜS Students Explore Pharma Industry Insights

    A Day of Discovery: BÜS Students Explore Pharma Industry Insights

    On March 20, 2023, TBD Pharmatech proudly hosted the bright minds of BÜS – a student organization from Tartu University that unites natural sciences students. BÜS aims to empower future biologists and promote their growth to the world’s top level by facilitating networking among current and future Estonian scientists, fostering a passion for scientific research, and advocating for the development of their respective fields. You can read more about BÜS here: https://www.bys.ee. We at TBD Pharmatech felt delighted to share our knowledge and expertise with these eager young scientists and offer them a firsthand glimpse into the pharmaceutical industry. A

    Read more
  • TBD Pharmatech at CPHI North America 2023

    TBD Pharmatech is excited to announce that we will be attending CPHI North America 2023, one of the most important events in the pharmaceutical industry. Our Chief Business Officer, Olga Tšubrik, will be representing our company at the event. As a professional pharmaceutical development and manufacturing company, we are looking forward to connecting with other industry professionals and sharing our latest innovations and advancements. CPHI North America is an important event for the pharmaceutical industry, providing a platform for companies to showcase their latest products and services. Attendees can expect to see the latest innovations in drug development, manufacturing, and

    Read more
  • TBD Pharmatech at DCAT Week 2023

    March 20-23 2023 TBD Pharmatech will be present at DCAT Week 2023! This is the first time TBD Pharmatech is attending DCAT Week. We are already looking forward to discuss CDMO collaboration! Book a meeting with TBD Pharmatech’s CBO Olga Tšubrik via LinkedIn, contact us via webpage or write directly to sales@tbdpharmatech.com. DCAT Week 2023 is the premier global event held annually in New York City for companies engaged in the Bio and Pharmaceutical Manufacturing Value Chain. It is hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, member-supported, global business development association whose unique membership model

    Read more
  • What are inactive pharmaceutical ingredients?

    What are inactive pharmaceutical ingredients?

    Inactive pharmaceutical ingredients (IPIs) are ingredients found in medication that do not directly affect the treatment of a disease or condition. While they may not be active, these components can still have an impact on the overall effectiveness of a drug. Understanding IPIs is important to ensure that your medications are working as intended. What do IPIs do? Inactive pharmaceutical ingredients come in many forms and serve a variety of purposes. For example, some are used as fillers and binding agents to help make tablets more consistent in size and shape. Others, such as colorings, flavorings, and preservatives, may be

    Read more
  • Project: PET-Diagnostics in collaboration with PharmIdea

    Project: PET-Diagnostics in collaboration with PharmIdea

    TBD Pharmatech worked on a PET-diagnostics project together with Latvian partner SIA PharmIdea from 2017 until 2019. The main objective of the Project was to develop a PET-product used in Positron emission tomography-computer tomography (PET-CT) for cancer, Alzheimer or Parkinson diagnostics. The outcome of the Project was final dosage form of the PET-product with all the documentation package, necessary for its implementation in nuclear medicine centers and hospitals. After the first Product has been developed and marketed, TBD and PharmIdea plan to continue the cooperation and develop the next PET-diagnostics and other products for oncology studies, studies of Alzheimer and

    Read more
  • LIOS and TBD Pharmatech join forces

    LIOS and TBD Pharmatech join forces

    On 21st February 2023, the Latvian Institute of Organic Synthesis (LIOS) and TBD Pharmatech signed the Memorandum of Understanding to strengthen the drug manufacturing performance of the Baltic region. The alliance will perform joint projects for manufacturing technology development and the production of active pharmaceutical ingredients (APIs). It will also support and promote new trends in API manufacturing such as the introduction of green technologies and advanced safety aspects. “Memorandum of understanding with TBD Pharmatech is a very important step forward for LIOS to become an integral part of the API technologies development ecosystem by linking our research capacities to

    Read more
  • Pharmaceutical compliance

    Pharmaceutical compliance

    Pharmaceutical compliance is a crucial part of the drug development process. It includes the processes and activities undertaken by a pharmaceutical company to ensure that its products meet all the applicable regulatory requirements. What is pharmaceutical compliance? Pharmaceutical compliance refers to the process of ensuring that a product or service meets all applicable regulations before it can be released to patients. This includes everything from making sure that the ingredients are properly sourced to ensuring that manufacturing processes meet stringent quality control standards. Compliance also applies to marketing materials, labeling requirements, and advertising regulations. Companies must ensure that their products

    Read more
  • Maarjavälja career day 2023

    Maarjavälja career day 2023

    On 9th of February the annual Maarjavälja career day 2023 took place. The career day is organized by Faculty of Science and Technology of University of Tartu. The event brings together companies and students from fields of chemistry, physics, genomics, molecular and cell biology etc. Hence, for students this is a perfect opportunity to meet their future internship and career possibilities. TBD Pharmatech participated in the career day to introduce the opportunities for students specializing in chemistry. As a one of a kind company in Estonia developing and producing API-s working at TBD Pharmatech is an unique option to start

    Read more
  • Medicine shortage: actions taken in Estonia and EU

    Medicine shortage: actions taken in Estonia and EU

    Lately the shortage of medicines and health products has become an important topic everywhere around the world. Health professionals from European countries, as well as from Canada and US have been warning about potential medicine shortage. In the end of December such effect were clear in Estonia too when antipyretic syrups were nowhere to be found. At the same time doctors needed to find alternative treatments for patients in need for some specific antibiotics since they were also short in supply. Causes of shortages The supply chain disruption in pharmaceuticals is actually nothing unprecedented. However, the past few years have

    Read more